Gelatinase-Mediated Impairment of Microvascular Beds in Cerebral Ischemia and Reperfusion Injury

Shanyan Chen,Hailong Song,Jiankun Cui,Joel I. Shenker,Yujie Chen,Grace Y. Sun,Hua Feng,Zezong Gu

DOI: https://doi.org/10.1007/978-3-319-90194-7_1

2018-01-01

Abstract:Stroke is one of the leading causes of death, and acute ischemic stroke (AIS) is the most common form. Tissue plasminogen activator (tPA) is the only FDA-approved drug for recanalization in AIS with narrow therapeutic window. In this chapter, we will discuss the activation of gelatinases (MMP-2/9), one of the major mediators in cerebral ischemia and reperfusion injury (CIRI) with exogenous tPA in AIS. First, we briefly overview the structure of microvascular beds and the homeostasis of neurovascular unit associated with the extracellular matrix (ECM). Then we review the gelatinase-mediated degradation of ECM and the impairment of microvascular beds in AIS. Moreover, we discuss the self-perpetuating loop of gelatinase activation in CIRI with exogenous tPA. At last, we literature available approaches showing protective functions through blocking the vicious circle of gelatinase activation, which may hold great promise in combined treatment with tPA in AIS.